Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatocellular carcinoma.

Jorge A Marrero1

  • 1Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan 48109-0362, USA. jmarrero@umich.edu

Current Opinion in Gastroenterology
|February 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review.

Gastroenterology·2026
Same author

Validation of Texas Hepatocellular Carcinoma Consortium Risk Index in the Hepatocellular Carcinoma Early Detection Strategy Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Shifts in Cohort Eligibility With Deimplementation of Race-specific Guidance for Hepatocellular Carcinoma Surveillance.

Gastro hep advances·2025
Same author

HES V2.0 validation and performance compared to GALAD and ASAP in the HEDS cohort.

Journal of hepatology·2025
Same author

Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.

Hepatology (Baltimore, Md.)·2025
Same author

AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.

Hepatology (Baltimore, Md.)·2025
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Hepatocellular carcinoma (HCC) research is growing. While alpha-fetoprotein is a common marker, new markers and advanced imaging like MRI are improving diagnosis, with transplantation, resection, and chemoembolization offering treatment options.

Area of Science:

  • Hepatology and Oncology
  • Gastroenterology
  • Medical Imaging

Background:

  • Rising incidence of hepatocellular carcinoma (HCC) linked to chronic hepatitis C, obesity, and nonalcoholic fatty liver disease.
  • Limitations of alpha-fetoprotein (AFP) as a tumor marker due to poor diagnostic accuracy and ethnic variability.
  • Emerging research in proteomic and genomic analyses for novel HCC biomarkers.

Purpose of the Study:

  • To review current trends and advancements in hepatocellular carcinoma (HCC) diagnosis and treatment.
  • To highlight the evolving landscape of HCC research and clinical management strategies.
  • To provide an overview of diagnostic modalities and therapeutic interventions for HCC.

Main Methods:

  • Review of recent publications on hepatocellular carcinoma (HCC).

Related Experiment Videos

  • Analysis of diagnostic accuracy of tumor markers and imaging techniques.
  • Evaluation of treatment outcomes for transplantation, surgical resection, and chemoembolization.
  • Assessment of chemoprevention strategies for HCC.

    • Main Results:

    • Dynamic gadolinium MRI shows higher sensitivity for HCC identification compared to spiral CT scans.
    • Surgical resection is a viable option for select early-stage HCC patients without portal hypertension.
    • Chemoembolization demonstrates survival benefits for unresectable HCC in Child class A and B patients.
    • Interferon therapy shows promise for HCC chemoprevention in chronic hepatitis C patients.

    Conclusions:

    • Advancements in imaging and biomarker discovery are improving HCC detection.
    • Multimodal treatment approaches including transplantation, resection, and chemoembolization offer survival benefits for HCC patients.
    • Chemoprevention strategies are crucial for reducing HCC incidence in high-risk populations.